Paul Dorian
Paul Dorian
Department Director, Division of Cardiology, and Staff Cardiac Electrophysiologist, St. Michael’s Hospital. Professor of Medicine, Division of Cardiology and Division of Clinical Pharmacology, University of Toronto, Toronto, Canada.
Dr. Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto.
Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He continued training in Internal Medicine and Cardiology at the University of Toronto, and received certification by the Royal College of Physicians and Surgeons of Canada in Internal Medicine in 1983 and certification in Cardiology in 1984. He completed training in Clinical Pharmacology at the University of Toronto in 1982, and received an MSc in Pharmacology from the University of Toronto in 1982. From 1983 to 1985, he completed a Fellowship in Cardiac Electrophysiology at Stanford University Medical Centre in California.
His research interests include basic science research in advanced cardiac life support, ventricular fibrillation, defibrillation, the clinical pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.
He has recently completed a clinical trial in out of hospital cardiac arrest and continues collaborative trials in prehospital care and resuscitation.
Department Director, Division of Cardiology, and Staff Cardiac Electrophysiologist, St. Michael’s Hospital. Professor of Medicine, Division of Cardiology and Division of Clinical Pharmacology, University of Toronto, Toronto, Canada.
Dr. Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael's Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto.Dr. Dorian received his medical degree from McGill University in Montreal in 1976. He continued training in Internal Medicine and Cardiology at the University of Toronto, and received certification by the Royal College of Physicians and Surgeons of Canada in Internal Medicine in 1983 and certification in Cardiology in 1984. He completed training in Clinical Pharmacology at the University of Toronto in 1982, and received an MSc in Pharmacology from the University of Toronto in 1982. From 1983 to 1985, he completed a Fellowship in Cardiac Electrophysiology at Stanford University Medical Centre in California.
His research interests include basic science research in advanced cardiac life support, ventricular fibrillation, defibrillation, the clinical pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.
He has recently completed a clinical trial in out of hospital cardiac arrest and continues collaborative trials in prehospital care and resuscitation.
- AF and its Management
- AF Facts and Figures
- Dronedarone (Multaq®) A new advance in the management of atrial fibrillation
- Dronedarone Clinical Trial Programme and Clinical Evidence
- Sanofi-aventis commitment and dedication in atrial fibrillation
- Speakers biographies
- Stroke-Risk Reduction in AF
- The ATHENA Study - Addressing the cardiovascular complications of atrial fibrillation
- Record AF
Latest videos
Latest Congress Announcement
ESC Congress 2011
This year, ESC Congress goes to Paris. The event is the year’s “Rendez-vous” for everybody involved in Cardiovascular Medicine, from clinical practitioners to basic scientists, epidemiologists, nurses, technicians, health care industry, opinion leaders and policy makers from around the world.
Paris, France.
Paris, France.

